Annals of Noninvasive Electrocardiology (Nov 2021)

Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy

  • Koji Takahashi,
  • Mina Yamashita,
  • Tomoki Sakaue,
  • Daijiro Enomoto,
  • Shigeki Uemura,
  • Takafumi Okura,
  • Shuntaro Ikeda,
  • Masafumi Takemoto,
  • Yutaka Utsunomiya,
  • Takashi Hyodo

DOI
https://doi.org/10.1111/anec.12842
Journal volume & issue
Vol. 26, no. 6
pp. n/a – n/a

Abstract

Read online

Abstract An elderly Japanese woman developed acute decompensated heart failure caused by persistent atrial fibrillation (AF) and left ventricular systolic dysfunction. Approximately 6 days after starting intravenous administration of amiodarone (600 mg/day) for maintaining sinus rhythm after cardioversion of AF, electrocardiograms revealed a prolonged QT interval associated with torsade de pointes (TdP). The amiodarone‐induced TdP disappeared after intravenous administration of landiolol plus magnesium and potassium, without discontinuation of amiodarone or overdrive cardiac pacing, although the prolonged QT interval persisted. To the best of our knowledge, this is the first report that landiolol could be effective for amiodarone‐induced TdP.

Keywords